The Latest Breaking News from Pfizer

All Australian adults who haven't had a COVID-19 booster or a confirmed case in the past six months are now eligible for an additional shot.

Katie Pritchard is having to crowdfund £200,000 for private treatment after she was twice misdiagnosed, being told her symptoms may have been down to the Pfizer vaccine and even being insulted by the suggestion it was an STI

LOS ANGELES — Black and Latino children in Los Angeles County younger than 5 have COVID-19 vaccination rates in the single digits, reflecting a broad trend nationwide that has public health experts concerned and seeking ways to boost those figures.

The film will follow the lives of five ordinary Welshmen as they go through an extraordinary journey which ultimately, and quite accidentally - led to the creation of the erectile dysfunction drug - Viagra

The pharma industry has experienced tremendous growth in recent years. The industry should continue to grow, driven by the growing market for personalized medicine and e-pharmacies. Hence, pharma stocks Pfizer (PFE), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and Zoetis (ZTS) might be worth buying for the long term. Also, these companies…

The Republic of Korea has donated over 500,000 doses of the bivalent Pfizer Covid-19 vaccine to Thailand to mark the 65th anniversary of diplomatic relations between the two countries.

January’s robust macroeconomic reports indicate that the Fed might raise the interest rates for longer than expected. Also, the dramatic rise in consumer debt in the fourth quarter of 2022 is a red signal for the economy. Hence, fundamentally strong stocks Pfizer (PFE), CVS Health (CVS), and Universal Logistics (ULH)…

The Public Health Ministry will begin the roll-out of Pfizer's BA.1 bivalent Covid-19 vaccine next month, according to Dr Thares Krasanairawiwong, chief of the Department of Disease Control (DDC).

Valneva stock plummeted Friday after Pfizer said it will drop roughly half of the participants enrolled in their Lyme disease vaccine study.

The protection against Covid-19 from being previously infected lasts at least as long as that offered by vaccination, one of the largest studies conducted on the subject said on Friday. Ten months after getting Covid, people still had an 88 percent lower risk of reinfection, hospitalization and death, according to…

One of the largest studies conducted on COVID immunity finds that previous infections provide protection for as long as vaccination, but experts caution vaccines are still the safer option.